Oracle Investment Management Inc. logo

Oracle Investment Management Inc.

North America, Connecticut, United States, Greenwich

Description

Oracle Investment Management, Inc. (OIM) is a fundamental research driven investment management company that is exclusively focused on the

Investor Profile

Oracle Investment Management Inc. has made 12 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Post Ipo Equity (75%)
  • Series B (17%)
  • Seed (8%)

Country Focus

  • United States (83%)
  • Canada (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Health Diagnostics
  • Oncology
  • Women's
  • Medical Device
  • Life Science
  • Blockchain
  • Cryptocurrency
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oracle Investment Management Inc. frequently co-invest with?

Halvings Capital
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
Extra Watts
Europe, Istanbul, Turkey, Istanbul
Co-Investments: 1
Down Under Capital
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
BF
North America, Vermont, United States, Burlington
Co-Investments: 2
Born This Way Foundation
North America, California, United States, Los Angeles
Co-Investments: 1
AU21 Capital
North America, California, United States, San Francisco
Co-Investments: 1
Dutch Crypto Investors
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Prospect Hill Growth Partners
North America, Massachusetts, United States, Waltham
Co-Investments: 1
Co-Investments: 1

Which angels does Oracle Investment Management Inc. often collaborate with?

FM
North America, California, United States, Mountain View
Shared Deals: 1
JS
North America, California, United States, Lake Forest
Shared Deals: 5
Matthew W. Strobeck
North America, Vermont, United States, Burlington
Shared Deals: 1
EM
North America, California, United States, Redwood City
Shared Deals: 1
LN
North America, Connecticut, United States, Greenwich
Shared Deals: 1

What are some of recent deals done by Oracle Investment Management Inc.?

Core Starters

Saint Vincent, Alberta, Canada

Core Starters services startups and investors through blockchain based decentralized services to solve real problems.

BlockchainCryptocurrencyFunding Platform
SeedNov 8, 2021
Amount Raised: $1,320,000
Pyramid Biosciences

Needham, Massachusetts, United States

Pyramid Biosciences is a provider of biotechnological services.

BiotechnologyLife Science
Series BOct 15, 2021
Amount Raised: $33,538,989
Concentric Analgesics

San Francisco, California, United States

Concentric Analgesics is a biotechnology company that develops non-opioid therapeutics for the management of acute and chronic pain.

BiotechnologyHealth CareMedicalMedical Device
Series BMay 22, 2019
Amount Raised: $77,100,822
Soleno Therapeutics

Redwood City, California, United States

Soleno Therapeutics is a clinical-stage biopharmaceutical company.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityDec 19, 2018
Amount Raised: $16,500,000
ContraFect

Yonkers, New York, United States

ContraFect is a biotechnology company researching the use of monoclonal antibodies to treat life-threatening infectious diseases.

BiotechnologyHealth CareMedical
Post Ipo EquityJun 25, 2015
Amount Raised: $20,000,000
Hansen Medical

Mountain View, California, United States

Hansen Medical designs and manufactures medical robotics for the accurate positioning and control of catheter-based technologies.

Health CareMedicalMedical Device
Post Ipo EquityMar 25, 2015
Amount Raised: $34,999,900
Aspira Women's Health

Austin, Texas, United States

Aspira Women's Health develops and commercializes diagnostic tests that address unmet needs in gynecologic oncology and women’s health.

BiotechnologyHealth CareHealth DiagnosticsOncologyWomen's
Post Ipo EquityDec 23, 2014
Amount Raised: $10,500,000
Yield10 Bioscience

Woburn, Massachusetts, United States

Yield10 Bioscience develops crop yield improvement solutions using advanced genetic engineering and synthetic biology techniques.

AgricultureAgTechBiotechnologySustainability
Post Ipo EquityAug 4, 2014
Amount Raised: $25,000,000
Transition Therapeutics

Toronto, Ontario, Canada

Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.

BiopharmaBiotechnologyTherapeutics
Post Ipo EquityJun 6, 2014
Amount Raised: $30,800,000
Biolase

Foothill Ranch, California, United States

Biolase develops lasers and related products for providing biological treatments that reduce pain.

3D PrintingBiotechnologyHealth CareManufacturingMedical Device
Post Ipo EquityFeb 11, 2014
Amount Raised: $5,000,000